Recognition of the superscan in prostatic bone scintigraphy

Area of Science:

• Nuclear medicine
• Radiology
• Oncology

Background:

• Bone scans using 99Tcm methylene diphosphonate (MDP) are crucial for detecting bone metastases.
• Widespread metastases can sometimes result in a 'superscan' appearance, mimicking normal scans.
• This can lead to misinterpretation and delayed diagnosis.

Purpose of the Study:

• To identify a method for distinguishing true normal bone scans from "superscans" caused by diffuse bone metastases.
• To evaluate the utility of an image quantitation index for this differentiation.
• To investigate the association of superscans with specific cancer types.

Main Methods:

• Analysis of bone scan imaging characteristics, focusing on bone to soft tissue activity ratios.
• Development and application of an image quantitation index.
• Comparison of superscan findings with other bone scan categories and patient diagnoses.

Main Results:

• Superscans exhibit a high bone to soft tissue activity ratio, absent focal axial lesions, and typically no renal images.
• The proposed image quantitation index effectively differentiates superscans from normal scans.
• Prostatic carcinoma is frequently associated with the superscan phenomenon.

Conclusions:

• The image quantitation index provides a reliable method to avoid misinterpreting superscans as normal bone scans.
• Accurate identification of superscans is vital for appropriate patient management, particularly in oncology.
• Superscans are a significant indicator of widespread bone metastases, often linked to prostate cancer.